Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank43
3Y CAGR-10.9%
5Y CAGR-64.4%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-10.9%/yr
Annual compound
5Y CAGR
-64.4%/yr
Recent acceleration
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.72 | -8.7% |
| 2024 | 10.65 | +54.5% |
| 2023 | 6.89 | -49.9% |
| 2022 | 13.76 | -97.8% |
| 2021 | 612.05 | -64.2% |
| 2020 | 1709.19 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |